NGS-Based RNA-Seq Market Is Estimated to Reach US$ 7,984.90 Mn by 2027 and Estimated to Grow with a CAGR of 19.3% from 2018-2027

The Insight partners has announced the addition of the NGS-Based RNA-Seq Market 2027 - Global Analysis and Forecasts by Functions, Size, Trends, Share, Technology, Status and Opportunities, Application report to their offering.

Logo

Pune, India -- (SBWire) -- 03/19/2019 --NGS-based RNA-seq Market was valued at US$ 1,240.87 Mn in 2017 and is estimated to reach US$ 7,984.90 Mn by 2027. The market is estimated to grow with a CAGR of 19.3% from 2018- 2027.The report highlights the trends prevalent in the global NGS- based RNA- seq market and the factors driving the market along with those that act as deterrents to its growth.

Global NGS- based RNA- seq market, based on the product & services is segmented into sample preparation, sequencing services, sequencing platform & consumables and data analysis, storage & management. The sample preparation segment is further bifurcated into method and workflow step segments. In 2017, sequencing platform & consumables segment held the largest share, by product& services. Additionally, the data analysis segment is anticipated to grow at a significant rate during the forecast period.

Top Leading Market Players:

1. Illumina, Inc.
2. Thermo Fisher Scientific Inc.
3. Pacific Biosciences of California, Inc.
4. Qaigen
5. F. Hoffmann-La Roche AG
6. Agilent Technologies, Inc.
7. BGI
8. Oxford Nanopore Technologies
9. Perkinelmer, Inc.
10. Eurofins Scientific

Get PDF Sample Copy of this Report @ https://www.theinsightpartners.com/sample/TIPBT00002556

The market players are focused towards bringing new and innovative product launches to sustain their position in the market. For instance, in October 2018, Agilent Technologies Inc. launched Agilent OnePGT, a genome- wide, next- generation sequencing (NGS) solution for preimplantation genetic testing (PGT).

Key Benefits-

- To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global NGS-based RNA-seq Market
- To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa).

Global NGS- based RNA- seq market is expected to grow in the coming years, owing to the factors such as, reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer. However, the risks related to genetic data and high cost of NGS instruments is act as a restraint for this market. On the other hand, barcode scanning for long reads sequences likely to add novel opportunities for NGS- based RNA- seq market, in the coming years.

The report segments the global NGS- Based RNA- Seq Market as follows:

Global NGS- Based RNA- Seq Market - By Product & Services

- Sample Preparation
- Method
- Manual Method
- Automated Method
- Workflow Step
- Library Preparation & Target Enrichment
- Fragmentation, End Repair & Size Selection
- Quality Control
- Sequencing Services
- Sequencing Platform & Consumables
- Data Analysis, Storage & Management

Global NGS- Based RNA- Seq Market - By Technology

- Sequencing By Synthesis
- Nanopore Sequencing
- Ion Semiconductor Sequencing
- Single-Molecule Real-Time (SMRT) Sequencing

Global NGS- Based RNA- Seq Market - By Application

- Diagnostics
- Drug Discovery
- Precision Medicine
- Others

Global NGS-Based RNA-Seq Market - By End User

- Hospitals & Clinics
- Research Centers and Academic & Government Institutes
- Biotechnology & Pharmaceutical Companies
- Others

Purchase for Report @ https://www.theinsightpartners.com/buy/TIPBT00002556/

What our report offers:

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Global NGS-based RNA-seq Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the NGS-based RNA-seq, thereby allowing players to develop effective long term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Media Relations Contact

Sameer Joshi
CEO
The Insight Partners
1-646-491-9876
https://www.theinsightpartners.com/

View this press release online at: http://rwire.com/1174970